Photocure Investor Relations Material
Latest events
Q2 2025
Photocure
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Photocure
Access all reports
Photocure ASA is a specialty pharmaceutical company engaged in the research, development, production, distribution, marketing and sale of pharmaceutical products. The Company's product portfolio consists of solid and semi-solid dosage forms including tablets, capsules, ointments and creams based on its patented drug delivery technologies. The Company has developed and commercialized proprietary formulations for medicines that are targeted primarily at cardiovascular indications.
Key slides for Photocure
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
PHO
Country
🇳🇴 Norway